Logo for Matinas BioPharma Holdings Inc

Matinas BioPharma Investor Relations Material

Latest events

Logo for Matinas BioPharma Holdings Inc

Q1 2024

Matinas BioPharma
Logo for Matinas BioPharma

Q1 2024

9 May, 2024
Logo for Matinas BioPharma

Q4 2023

27 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Matinas BioPharma Holdings Inc

Access all reports
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of various product candidates for the treatment of cancer and other orphan diseases. The company explores next-generation chemotherapeutic drugs that bring an optimal therapeutic benefit to patients with high unmet medical needs. One of the company's lead drug candidates is for the treatment of tumors resistant to conventional therapies such as chemotherapy or radiation therapy.